|
Volumn 57, Issue 9-10, 2004, Pages 462-467
|
Ras signaling pathway as a target for farnesyltransferase inhibitors--a new, promising prospects in the treatment for malignant disorders;Droga sygnałowa ras jako cel działania inhibitorów transferazy farnezylu--nowe, obiecujace mozliwości leczenia chorób nowotworowych.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FARNESYL TRANS TRANSFERASE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
GUANOSINE TRIPHOSPHATE;
IMIDAZOLE DERIVATIVE;
L 778,123;
LONAFARNIB;
PIPERIDINE DERIVATIVE;
PYRIDINE DERIVATIVE;
QUINOLONE DERIVATIVE;
TIPIFARNIB;
TRANSFERASE;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
HUMAN;
METABOLISM;
NEOPLASM;
ONCOGENE RAS;
POINT MUTATION;
REVIEW;
SIGNAL TRANSDUCTION;
ALKYL AND ARYL TRANSFERASES;
ANTINEOPLASTIC AGENTS;
FARNESYLTRANSTRANSFERASE;
GENES, RAS;
GTP-BINDING PROTEINS;
GUANOSINE TRIPHOSPHATE;
HUMANS;
IMIDAZOLES;
NEOPLASMS;
PIPERIDINES;
POINT MUTATION;
PYRIDINES;
QUINOLONES;
SIGNAL TRANSDUCTION;
|
EID: 18444387414
PISSN: 00435147
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (31)
|